Institutional Ownership Supernus Pharmaceuticals, Inc. (SUPN)
This table provides information about the institutional ownership of Supernus Pharmaceuticals, Inc. (SUPN). We have compiled data on the 312 institutions that hold shares in the stock, with a total of 61.7 Million shares, which have been reported (via 13F filing form) to have a value of $2.84 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Pictet Asset Management Holding Sa
Carouge, V8 |
Aug 13, 2025 Q2 2025 |
554,482
shares
|
$25.5 Million
0.02% of portfolio
|
Q2 2025
Added 1.94%
|
|
Rice Hall James & Associates, LLC
|
Aug 11, 2025 Q2 2025 |
524,647
shares
|
$24.1 Million
0.98% of portfolio
|
Q2 2025
Added 1.7%
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
509,360
shares
|
$23.4 Million
0.0% of portfolio
|
Q1 2025
Added 71.04%
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Aug 14, 2025 Q2 2025 |
507,790
shares
|
$23.4 Million
0.04% of portfolio
|
Q2 2025
Added 59.23%
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
504,306
shares
|
$23.2 Million
0.0% of portfolio
|
Q2 2025
Added 4.39%
|
|
Krensavage Asset Management, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
472,376
shares
|
$21.7 Million
7.88% of portfolio
|
Q2 2025
Added 9.35%
|
|
International Biotechnology Trust PLC
London, X0 |
Nov 14, 2023 Q3 2023 |
426,500
shares
|
$19.6 Million
3.99% of portfolio
|
Q3 2023
Reduced 18.53%
|
|
Invesco Ltd.
Atlanta, GA |
Aug 13, 2025 Q2 2025 |
399,019
shares
|
$18.4 Million
0.0% of portfolio
|
Q2 2025
Reduced 24.8%
|
|
Tributary Capital Management, LLC
|
Jul 30, 2025 Q2 2025 |
308,587
shares
|
$14.2 Million
0.85% of portfolio
|
Q2 2025
Reduced 7.05%
|
|
Principal Financial Group Inc
Des Moines, IA |
Aug 08, 2025 Q2 2025 |
305,631
shares
|
$14.1 Million
0.01% of portfolio
|
Q2 2025
Reduced 0.23%
|
|
Pacer Advisors, Inc.
Malvern, PA |
Aug 12, 2025 Q2 2025 |
288,231
shares
|
$13.3 Million
0.03% of portfolio
|
Q2 2025
Reduced 28.59%
|
|
Sei Investments CO
Oaks, PA |
Aug 14, 2025 Q2 2025 |
269,906
shares
|
$12.4 Million
0.01% of portfolio
|
Q2 2025
Added 10.57%
|
|
Schroder Investment Management Group
London, X0 |
Aug 13, 2025 Q2 2025 |
266,927
shares
|
$12.3 Million
0.01% of portfolio
|
Q2 2025
Reduced 0.95%
|
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
Aug 13, 2025 Q2 2025 |
247,977
shares
|
$11.4 Million
0.01% of portfolio
|
Q2 2025
Reduced 3.29%
|
|
Systematic Financial Management LP
Teaneck, NJ |
Aug 13, 2025 Q2 2025 |
245,545
shares
|
$11.3 Million
0.22% of portfolio
|
Q2 2025
Added 47.47%
|
|
Qube Research & Technologies LTD
London, X0 |
Aug 14, 2025 Q2 2025 |
229,710
shares
|
$10.6 Million
0.01% of portfolio
|
Q2 2025
Added 134.21%
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
227,348
shares
|
$10.5 Million
0.0% of portfolio
|
Q2 2025
Reduced 9.18%
|
|
Public Sector Pension Investment Board
Montreal, A8 |
Aug 12, 2025 Q2 2025 |
220,304
shares
|
$10.1 Million
0.03% of portfolio
|
Q2 2025
Added 0.26%
|
|
Mutual Of America Capital Management LLC
New York, NY |
Jul 29, 2025 Q2 2025 |
212,691
shares
|
$9.79 Million
0.07% of portfolio
|
Q2 2025
Added 5.31%
|
|
Scout Investments, Inc.
|
Nov 12, 2024 Q3 2024 |
208,613
shares
|
$9.6 Million
0.19% of portfolio
|
Q3 2024
Reduced 13.91%
|
|
Third Avenue Management LLC
New York, NY |
Aug 13, 2025 Q2 2025 |
189,493
shares
|
$8.72 Million
1.42% of portfolio
|
Q3 2024
Added 0.2%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
175,134
shares
|
$8.06 Million
0.0% of portfolio
|
Q2 2025
Added 8.43%
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Aug 14, 2025 Q2 2025 |
173,175
shares
|
$7.97 Million
0.0% of portfolio
|
Q2 2025
Reduced 61.74%
|
|
Rhumbline Advisers
Boston, MA |
Aug 12, 2025 Q2 2025 |
172,230
shares
|
$7.93 Million
0.0% of portfolio
|
Q2 2025
Added 4.18%
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Aug 14, 2025 Q2 2025 |
167,692
shares
|
$7.72 Million
0.0% of portfolio
|
Q2 2025
Added 55.57%
|